Xvivo Perfusion AB (publ) (STO:XVIVO)
185.70
+6.80 (3.80%)
At close: Dec 5, 2025
-60.24% (1Y)
| Market Cap | 5.85B |
| Revenue (ttm) | 813.59M |
| Net Income (ttm) | 29.90M |
| Shares Out | 31.50M |
| EPS (ttm) | 0.95 |
| PE Ratio | 195.63 |
| Forward PE | 50.94 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 174,813 |
| Average Volume | 175,599 |
| Open | 181.20 |
| Previous Close | 178.90 |
| Day's Range | 181.20 - 188.30 |
| 52-Week Range | 160.00 - 519.00 |
| Beta | 1.84 |
| RSI | 58.07 |
| Earnings Date | Jan 27, 2026 |